Association of Anaemia With Higher Mortality and Disability After Subarachnoid Haemorrhage: A Single-Centre Cohort Study
- PMID: 40421344
- PMCID: PMC12105551
- DOI: 10.7759/cureus.83031
Association of Anaemia With Higher Mortality and Disability After Subarachnoid Haemorrhage: A Single-Centre Cohort Study
Abstract
Background: Critical care management in subarachnoid haemorrhage (SAH) aims to facilitate neuroprotection and prevent secondary neurological insults. Anaemia after SAH leads to reduced cerebral oxygen delivery and poor outcomes. This study aimed to investigate the association between anaemia and mortality and morbidity outcomes in patients with SAH in tertiary centres, as well as evaluate the impact of blood transfusions on outcomes in anaemic SAH patients. Methods: We performed a retrospective study of 987 patients with SAH at a tertiary neurocritical care centre between September 2016 and September 2018. Data were collected on baseline characteristics, World Federation of Neurosurgical Societies SAH grade, secondary insults such as anaemia and hydrocephalus, and units of blood transfused. The primary outcome was to investigate the correlation between anaemia and 28-day Modified Rankin Scale (MRS) score. Secondary outcomes were delayed neurological deficits, length of stay and death in the intensive care unit (ICU). Anaemia was defined as haemoglobin (Hb) ≤ 95 g/L, and severe anaemia as Hb≤80 g/L. Results: Of the patients, 28.7% had anaemia and 12% had severe anaemia. Anaemia after SAH was associated with an increased risk of death or severe disability (p<0.001), worse survival outcomes (p<0.001) and increased length of stay in ICU (p<0.001).
Conclusions: Anaemia after SAH is associated with a significant increase in mortality and morbidity and should be monitored closely and corrected.
Keywords: acute subarachnoid haemorrhage; anaemia; blood transfusion; intracerebral aneurysms; neurointensive care unit.
Copyright © 2025, Ramesh et al.
Conflict of interest statement
Human subjects: Consent for treatment and open access publication was obtained or waived by all participants in this study. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Figures
Similar articles
-
Outcome after Hunt and Hess Grade V subarachnoid hemorrhage: a comparison of pre-coiling era (1980-1995) versus post-ISAT era (2005-2014).J Neurosurg. 2018 Jan;128(1):100-110. doi: 10.3171/2016.8.JNS161075. Epub 2017 Feb 24. J Neurosurg. 2018. PMID: 28298025
-
Anaemia on admission is associated with more severe intracerebral haemorrhage and worse outcomes.Int J Stroke. 2015 Apr;10(3):382-7. doi: 10.1111/j.1747-4949.2012.00951.x. Epub 2013 Mar 7. Int J Stroke. 2015. PMID: 23464747
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Outcome in poor grade subarachnoid hemorrhage patients treated with acute endovascular coiling of aneurysms and aggressive intensive care.Neurocrit Care. 2011 Jun;14(3):341-7. doi: 10.1007/s12028-010-9377-7. Neurocrit Care. 2011. PMID: 20464529
-
Erythropoietin plus iron versus control treatment including placebo or iron for preoperative anaemic adults undergoing non-cardiac surgery.Cochrane Database Syst Rev. 2020 Aug 13;8(8):CD012451. doi: 10.1002/14651858.CD012451.pub2. Cochrane Database Syst Rev. 2020. PMID: 32790892 Free PMC article.
References
-
- Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Bederson JB, Connolly ES Jr, Batjer HH, et al. Stroke. 2009;40:994–1025. - PubMed
-
- Intensive care management of subarachnoid haemorrhage. Highton D, Smith M. J Intensive Care Soc. 2013;14:28–35.
-
- Impact of medical complications on outcome after subarachnoid hemorrhage. Wartenberg KE, Schmidt JM, Claassen J, et al. Crit Care Med. 2006;34:617–624. - PubMed
-
- Hyperglycemia after SAH: predictors, associated complications, and impact on outcome. Frontera JA, Fernandez A, Claassen J, et al. Stroke. 2006;37:199–203. - PubMed
LinkOut - more resources
Full Text Sources